MIR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Wu, Shihua ^a,b   Liu, Feng ^a   Xie, Liming ^a   Peng, Yaling ^b   Lv, Xiaoyuan ^b   Zhu, Yaping ^b   Zhang, Zhiwei ^a   He, Xiusheng ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Shaoyang Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MICRORNA 125B; PROTEIN MCL 1; MCL1 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN125 MICRORNA, HUMAN; RNA;

ADULT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NEOPLASM INVASIVENESS; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; TRANSFECTION; UP-REGULATION;

EID: 84945386013     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/365273     Document Type: Article

References (28)

1. J. G. Misleh, P. Santoro, J. F. Strasser, and J. J. Bennett, "Multi-disciplinary management of gastric cancer, " Surgical Oncology Clinics of North America, vol. 22, no. 2, pp. 247-264, 2013.
2. H. Tang, Y. Kong, J. Guo et al., "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22, " Cancer Letters, vol. 340, no. 1, pp. 72-81, 2013.
3. L. Xie, Z. Zhang, Z. Tan et al., "MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer, " Molecular and Cellular Biochemistry, vol. 392, pp. 153-159, 2014.
4. I. Slezak-Prochazka, D. Selvi, B.-J. Kroesen, and A. van den Berg, "MicroRNAs, macrocontrol: regulation of miRNA processing, " RNA, vol. 16, no. 6, pp. 1087-1095, 2010.
5. T. Kunej, I. Godnic, J. Ferdin, S. Horvat, P. Dove, and G. A. Calin, "Epigenetic regulation of microRNAs in cancer: an integrated review of literature, " Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 717, no. 1-2, pp. 77-84, 2011.
6. F. E. Nicolas and A. F. Lopez-Martinez, "MicroRNAs in human diseases, " Recent Patents on DNA and Gene Sequences, vol. 4, no. 3, pp. 142-154, 2010.
7. H. Tang, P. Liu, L. Yang et al., "miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly up-regulating BRCA1 in triple negative breast cancer, " Molecular Cancer Therapeutics, vol. 13, no. 12, pp. 3185-3197, 2014.
8. H. Tang, M. Deng, Y. Tang et al., "MiR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression, " Clinical Cancer Research, vol. 19, no. 20, pp. 5602-5612, 2013.
9. Z. Tan, H. Jiang, Y. Wu et al, "MiR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer, " Molecular and Cellular Biochemistry, vol. 386, no. 1-2, pp. 223-231, 2014.
10. Y. Han, Y. Liu, H. Zhang et al., "Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1, " FEBS Letters, vol. 587, no. 23, pp. 3875-3882, 2013.
11. A. Feliciano, J. Castellvi, A. Artero-Castro et al., "miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-a, CCNJ, and MEGF9, " PLoS ONE, vol. 8, no. 10, Article ID e76247, 2013.
12. M. Shiiba, K. Shinozuka, K. Saito et al., "MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma, " British Journal of Cancer, vol. 108, no. 9, pp. 1817-1821, 2013.
13. M. Ferracin, C. Bassi, M. Pedriali et al., "miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression, " Molecular Cancer, vol. 12, no. 1, article 130, 2013.
14. M. Fassan, M. Pizzi, S. Realdon et al., "The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis, " Human Pathology, vol. 44, no. 9, pp. 1804-1810, 2013.
15. J. G. Wu, J. J. Wang, X. Jiang et al., "MiR-125b promotes cell migration and invasion by targeting PPPICA-Rb signal pathways in gastric cancer, resulting in a poor prognosis, " Gastric Cancer, 2014.
16. B. Zhang and M. A. Farwell, "MicroRNAs: a new emerging class of players for disease diagnostics and gene therapy: translational Medicine, " Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 3-21, 2008.
17. Z.-X. Yang, C.-Y Lu, Y.-L. Yang, K.-E Dou, and K.-S. Tao, "MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells, " Molecular Medicine Reports, vol. 7, no. 1, pp. 229-232, 2013.
18. J. Zhang, Y Zhang, S. Liu et al., "Metadherin confers chemore-sistance of cervical cancer cells by inducing autophagy and activating ERK/NF-/cB pathway, " Tumor Biology, vol. 34, no. 4, pp. 2433-2440, 2013.
19. K. Zhu, Z. Dai, Q. Pan et al., "Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition, " Clinical Cancer Research, vol. 17, no. 23, pp. 7294-7302, 2011.
20. R. J. Youle and A. Strasser, "The BCL-2 protein family: opposing activities that mediate cell death, " Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 47-59, 2008.
21. R.-Y Li, L.-C. Chen, H.-Y Zhang et al., "MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma, " CNS Neuroscience and Therapeutics, vol. 19, no. 7, pp. 477-483, 2013.
22. E Lu, J. Zhang, M. Ji et al., "miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and MCL-1, " Jnternational Journal of Oncology, vol. 45, no. 1, pp. 383-392, 2014.
23. 2+ uptake and reactive oxygen species generation, " Cell Death and Disease, vol. 5, no. 10, Article ID el482, 2014.
24. J. Gao, L. Li, M. Wu et al., "MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1, " PLoS ONE, vol. 8, no. 6, Article ID e65138, 2013.
25. Y.-M. Rao, H.-R. Shi, M. Ji, and C.-H. Chen, "MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells, " Journal of Huazhong University of Science and Technology-Medical Science, vol. 33, no. 4, pp. 567-572, 2013.
26. E Ye, H. Tang, Q. Liu et al., "miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family, " Journal of Translational Medicine, vol. 12, article 17, 2014.
27. G. Di Leva, M. Garofalo, and G M. Croce, "MicroRNAs in cancer, " Annual Review of Pathology, vol. 9, pp. 287-314, 2014.
28. C. K. Kontos, M.-I. Christodoulou, and A. Scorilas, "Apoptosis-related BCL2-family members: key players in chemotherapy, " Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 3, pp. 353-374, 2014.